These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 15922623

  • 1. Preparation and characterization of fusion protein truncated Pseudomonas Exotoxin A (PE38KDEL) in Escherichia coli.
    Song S, Xue J, Fan K, Kou G, Zhou Q, Wang H, Guo Y.
    Protein Expr Purif; 2005 Nov; 44(1):52-7. PubMed ID: 15922623
    [Abstract] [Full Text] [Related]

  • 2. Expression and purification of recombinant immunotoxin--a fusion protein stabilizes a single-chain Fv (scFv) in denaturing condition.
    Kim SH.
    Protein Expr Purif; 2003 Jan; 27(1):85-9. PubMed ID: 12509988
    [Abstract] [Full Text] [Related]

  • 3. Optimization of expression and purification of two biologically active chimeric fusion proteins that consist of human interleukin-13 and Pseudomonas exotoxin in Escherichia coli.
    Joshi BH, Puri RK.
    Protein Expr Purif; 2005 Feb; 39(2):189-98. PubMed ID: 15642470
    [Abstract] [Full Text] [Related]

  • 4. Expression, purification, and characterization of an immunotoxin containing a humanized anti-CD25 single-chain fragment variable antibody fused to a modified truncated Pseudomonas exotoxin A.
    Wang H, Dai J, Li B, Fan K, Peng L, Zhang D, Cao Z, Qian W, Wang H, Zhao J, Guo Y.
    Protein Expr Purif; 2008 Mar; 58(1):140-7. PubMed ID: 17950620
    [Abstract] [Full Text] [Related]

  • 5. Recombinant immunotoxins containing the VH or VL domain of monoclonal antibody B3 fused to Pseudomonas exotoxin.
    Brinkmann U, Lee BK, Pastan I.
    J Immunol; 1993 Apr 01; 150(7):2774-82. PubMed ID: 8454854
    [Abstract] [Full Text] [Related]

  • 6. Preparation and characterization of PE38KDEL-loaded anti-HER2 nanoparticles for targeted cancer therapy.
    Chen H, Gao J, Lu Y, Kou G, Zhang H, Fan L, Sun Z, Guo Y, Zhong Y.
    J Control Release; 2008 Jun 24; 128(3):209-16. PubMed ID: 18450313
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A method for increasing the yield of properly folded recombinant fusion proteins: single-chain immunotoxins from renaturation of bacterial inclusion bodies.
    Buchner J, Pastan I, Brinkmann U.
    Anal Biochem; 1992 Sep 24; 205(2):263-70. PubMed ID: 1332541
    [Abstract] [Full Text] [Related]

  • 9. Molecular construction and characterization of a novel exotoxin fusion protein that selectively blocks the B7:CD28 costimulatory signal system.
    Xi Y, Yuan Z, Zhang H, Guan H, Kong F, Liu N, Liang F, Cui J, Guo S, Sun Y, Xi C.
    J Immunother; 2006 Sep 24; 29(6):586-95. PubMed ID: 17063121
    [Abstract] [Full Text] [Related]

  • 10. Codon optimization enhances secretory expression of Pseudomonas aeruginosa exotoxin A in E. coli.
    Wang X, Li X, Zhang Z, Shen X, Zhong F.
    Protein Expr Purif; 2010 Jul 24; 72(1):101-6. PubMed ID: 20172029
    [Abstract] [Full Text] [Related]

  • 11. [Construction, expression and functional characterization of disulfide-stabilized anti-hepatocarcinoma single chain Fv fused with truncated Pseudomonas exotoxin].
    Zhao J, Sun ZW, Liu YF, Yu WY.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Nov 24; 19(6):585-7. PubMed ID: 15182657
    [Abstract] [Full Text] [Related]

  • 12. Recombinant anti-erbB2 immunotoxins containing Pseudomonas exotoxin.
    Batra JK, Kasprzyk PG, Bird RE, Pastan I, King CR.
    Proc Natl Acad Sci U S A; 1992 Jul 01; 89(13):5867-71. PubMed ID: 1352878
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Construction and recombinant expression of Pseudomonas aeruginosa truncated exotoxin A in Escherichia coli.
    Qaiser H, Aslam F, Iftikhar S, Farooq A.
    Cell Mol Biol (Noisy-le-grand); 2018 Jan 31; 64(1):64-69. PubMed ID: 29412796
    [Abstract] [Full Text] [Related]

  • 15. Fusogenics: a recombinant immunotoxin-based screening platform to select internalizing tumor-specific antibody fragments.
    Cizeau J, Torres MG, Cowling SG, Stibbard S, Premsukh A, Entwistle J, MacDonald GC.
    J Biomol Screen; 2011 Jan 31; 16(1):90-100. PubMed ID: 21131595
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Single-chain immunotoxin fusions between anti-Tac and Pseudomonas exotoxin: relative importance of the two toxin disulfide bonds.
    Kreitman RJ, Batra JK, Seetharam S, Chaudhary VK, FitzGerald DJ, Pastan I.
    Bioconjug Chem; 1993 Jan 31; 4(2):112-20. PubMed ID: 7873642
    [Abstract] [Full Text] [Related]

  • 20. Stabilization of the Fv fragments in recombinant immunotoxins by disulfide bonds engineered into conserved framework regions.
    Reiter Y, Brinkmann U, Kreitman RJ, Jung SH, Lee B, Pastan I.
    Biochemistry; 1994 May 10; 33(18):5451-9. PubMed ID: 7910034
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.